Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

ProMIS Neurosciences Inc PMN

ProMIS Neurosciences Inc. is a clinical-stage biotechnology company. It is focused on generating and developing antibody therapeutics selectively targeting toxic misfolded proteins in neurodegenerative diseases such as Alzheimer’s disease (AD), amyotrophic lateral sclerosis (ALS) and multiple system atrophy (MSA). Its proprietary target discovery engine applies a thermodynamic, computational discovery platform-ProMIS and Collective Coordinates-to predict novel targets known as Disease Specific Epitopes on the molecular surface of misfolded proteins. Using this approach, the Company is developing novel antibody therapeutics for AD, ALS and MSA. Its product candidates are PMN310, PMN267, and PMN442. The PMN310 is a monoclonal antibody designed to treat AD by selectively targeting toxic, misfolded oligomers of amyloid-beta. PMN267 product candidate targeting ALS. PMN442 is a drug candidate being developed for MSA designed to selectively target and protect against pathogenic a-syn species.


NDAQ:PMN - Post by User

Bullboard Posts
Post by Chainsawwon Dec 29, 2010 11:03pm
280 Views
Post# 17904725

TODAYS TRADES DEC 29

TODAYS TRADES DEC 29Same sellers as usual but a couple new buyers stepping in. The chart is looking ready soon for another move and the market depth is looking good to back this up. Not much on the offer side and if we break out through .50 we are on a new run.

Trades for C:AMF on 20101229 - 26 trades displayed
Time ET Ex Price Change Volume Buyer Seller Markers
14:33:08 T 0.45 0.02 2,500 85 Scotia 85 Scotia K
14:33:08 T 0.43 0.00 500 85 Scotia 85 Scotia K
14:27:51 T 0.43 0.00 1,000 7 TD Sec 85 Scotia K
14:27:51 T 0.43 0.00 2,500 7 TD Sec 85 Scotia K
14:15:32 T 0.45 0.02 2,500 2 RBC 85 Scotia K
14:15:32 T 0.445 0.015 1,000 2 RBC 19 Desjardins K
13:29:52 T 0.43 0.00 100 19 Desjardins 80 National Bank E
13:29:52 T 0.43 0.00 300 19 Desjardins 80 National Bank E
13:29:52 T 0.43 0.00 100 19 Desjardins 80 National Bank E
13:29:52 T 0.43 0.00 100 19 Desjardins 80 National Bank E
13:29:52 T 0.43 0.00 2,500 7 TD Sec 2 RBC K
13:29:52 T 0.43 0.00 4,500 7 TD Sec 2 RBC K
12:53:29 T 0.42 -0.01 350 19 Desjardins 80 National Bank E
12:53:29 T 0.42 -0.01 2,500 2 RBC 46 Macquarie K
12:45:37 T 0.42 -0.01 27,500 33 Canaccord 46 Macquarie K
11:22:50 T 0.41 -0.02 4,000 7 TD Sec 80 National Bank K
10:47:58 T 0.42 0.00 200 85 Scotia 80 National Bank E
10:47:58 T 0.43 0.00 1,500 85 Scotia 2 RBC K
09:33:18 T 0.43 0.00 2,000 60 MF Global Can 2 RBC K
09:33:18 T 0.43 0.00 3,500 60 MF Global Can 80 National Bank K
09:33:18 T 0.43 0.00 6,500 60 MF Global Can 80 National Bank K
09:30:47 T 0.40 0.00 100 19 Desjardins 7 TD Sec E
09:30:32 T 0.43 0.00 500 60 MF Global Can 80 National Bank K
09:30:32 T 0.43 0.00 3,000 60 MF Global Can 80 National Bank K
09:30:32 T 0.43 0.00 8,000 60 MF Global Can 1 Anonymous K
09:30:00 T 0.43 0.00 10,000 15 UBS 1 Anonymous KL

Bullboard Posts